Genome analyses of colistin-resistant high-risk blaNDM-5 producing Klebsiella pneumoniae ST147 and Pseudomonas aeruginosa ST235 and ST357 in clinical settings

Walesch S, Birkelbach J, Jézéquel G, Haeckl FPJ, Hegemann JD, Hesterkamp T, et al. Fighting antibiotic resistance—strategies and (pre) clinical developments to find new antibacterials. EMBO Rep. 2023;24.

Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399:629–55.

Article  CAS  Google Scholar 

Algammal AM, Wahdan A, Elhaig MM. Potential efficiency of conventional and advanced approaches used to detect Mycobacterium bovis in cattle. Microb Pathog. 2019;134.

Elbehiry A, Marzouk E, Aldubaib M, Moussa I, Abalkhail A, Ibrahem M, et al. Pseudomonas species prevalence, protein analysis, and antibiotic resistance: an evolving public health challenge. AMB Express. 2022;12.

Algammal AM, Hashem MEA, Alfifi KJ, Al-Otaibi AS, Alatawy M, Eltarabili RM, et al. Sequence analysis, Antibiogram profile, virulence and antibiotic resistance genes of XDR and MDR Gallibacterium anatis isolated from layer chickens in Egypt. Infect Drug Resist. 2022;15:4321–34.

Article  PubMed  PubMed Central  Google Scholar 

Algammal AM, Ibrahim RA, Alfifi KJ, Ghabban H, Alghamdi S, Kabrah A, et al. A first report of molecular typing, virulence traits, and phenotypic and genotypic resistance patterns of newly emerging XDR and MDR Aeromonas veronii in Mugil seheli. Pathogens. 2022;11.

Kareem SM, Al-Kadmy IMS, Kazaal SS, Ali ANM, Aziz SN, Makharita RR, et al. Detection of gyrA and parC mutations and prevalence of plasmid-mediated quinolone resistance genes in Klebsiella pneumoniae. Infect Drug Resist. 2021;14:555–63.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shafiq M, Zeng M, Permana B, Bilal H, Huang J, Yao F, et al. Coexistence of blaNDM–5 and tet(X4) in international high-risk Escherichia coli clone ST648 of human origin in China. Front Microbiol. 2022;13.

Peirano G, Chen L, Kreiswirth BN, Pitout JDD. Emerging Antimicrobial-Resistant High-Risk Klebsiella pneumoniae Clones ST307 and ST147. Antimicrob Agents Chemother. 2020;64(10):e01148–20. https://doi.org/10.1128/AAC.01148-20.

Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016;16:161–8.

Article  PubMed  Google Scholar 

Gogry FA, Siddiqui MT, Sultan I, Haq QMR. Current update on intrinsic and acquired Colistin resistance mechanisms in Bacteria. Front Med. 2021;8.

Haeili M, Javani A, Moradi J, Jafari Z, Feizabadi MM, Babaei E. MgrB alterations mediate colistin resistance in Klebsiella pneumoniae isolates from Iran. Front Microbiol. 2017;8.

Yap PSX, Cheng WH, Chang SK, Lim SHE, Lai KS. MgrB mutations and altered cell permeability in Colistin resistance in Klebsiella pneumoniae. Cells. 2022;11.

Giordano C, Barnini S, Tsioutis C, Chlebowicz MA, Scoulica EV, Gikas A, et al. Expansion of KPC-producing Klebsiella pneumoniae with various mgrB mutations giving rise to colistin resistance: the role of ISL3 on plasmids. Int J Antimicrob Agents. 2018;51:260–5.

Article  CAS  PubMed  Google Scholar 

Kocsis B, Kádár B, Tóth Á, Fullár A, Szabó D. MgrB variants in colistin-susceptible and colistin-resistant Klebsiella pneumoniae ST258. J Microbiol Immunol Infect. 2017;50:735–6.

Article  CAS  PubMed  Google Scholar 

Song Y, Yang J, Ju Y, Liu D, Wang Y, Sun X, et al. Genomic insights into a complete deletion of the mgrB locus in colistin-resistant Klebsiella pneumoniae ST2268 isolated from a human infection. J Glob Antimicrob Resist. 2021;27:75–8.

Article  PubMed  Google Scholar 

Jaidane N, Bonnin RA, Mansour W, Girlich D, Creton E, Cotellon G, et al. Genomic insights into colistin-resistant Klebsiella pneumoniae from a tunisian teaching hospital. Antimicrob Agents Chemother. 2020;64(10):e01148-20. https://doi.org/10.1128/AAC.01148-20.

Halaby T, Kucukkose E, Janssen AB, Rogers MRC, Doorduijn DJ, van der Zanden AGM, et al. Genomic characterization of colistin heteroresistance in Klebsiella pneumoniae during a nosocomial outbreak. Antimicrob Agents Chemother. 2016;60:6837–43.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ghafur A, Shankar C, GnanaSoundari P, Venkatesan M, Mani D, Thirunarayanan MA, et al. Detection of chromosomal and plasmid-mediated mechanisms of colistin resistance in Escherichia coli and Klebsiella pneumoniae from Indian food samples. J Glob Antimicrob Resist. 2019;16:48–52.

Article  PubMed  Google Scholar 

Nirwan PK, Chatterjee N, Panwar R, Dudeja M, Jaggi N. Mutations in two component system (PhoPQ and PmrAB) in colistin resistant Klebsiella pneumoniae from north Indian tertiary care hospital. J Antibiot. 2021;74:450–7.

Article  CAS  Google Scholar 

Lee JY, Chung ES, Na IY, Kim H, Shin D, Ko KS. Development of colistin resistance in pmrA-, phoP-, parR- and cprR-inactivated mutants of Pseudomonas aeruginosa. J Antimicrob Chemother. 2014;69:2966–71.

Article  CAS  PubMed  Google Scholar 

Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18:318–27.

Article  PubMed  Google Scholar 

Chen Q, Wang M, Han M, Xu L, Zhang H. Molecular basis of Klebsiella pneumoniae colonization in host. Microb Pathog. 2023;177.

Karami-Zarandi M, Rahdar HA, Esmaeili H, Ranjbar R. Klebsiella pneumoniae : an update on antibiotic resistance mechanisms. Future Microbiol. 2023; https://doi.org/10.2217/FMB-2022-0097.

le Guern R, Grandjean T, Stabler S, Bauduin M, Gosset P, Kipnis É, et al. Gut colonisation with multidrug-resistant Klebsiella pneumoniae worsens Pseudomonas aeruginosa lung infection. Nat Commun. 2023;14:78.

Article  PubMed  PubMed Central  Google Scholar 

Xu Q, Zheng B, Shen P, Xiao Y. Protective efficacy of statins in patients with Klebsiella pneumoniae bloodstream infection. Front Cell Infect Microbiol. 2023;12.

Karampatakis T, Tsergouli K, Behzadi P. Carbapenem-resistant Klebsiella pneumoniae: virulence factors, molecular epidemiology and latest updates in treatment options. Antibiotics (Basel). 2023;12.

Behzadi P, García-Perdomo HA, Karpiński TM, Issakhanian L. Metallo-ß-lactamases: a review. Mol Biol Rep. 2020;47:6281–94.

Article  CAS  PubMed  Google Scholar 

Algammal A, Hetta HF, Mabrok M, Behzadi P. Editorial: emerging multidrug-resistant bacterial pathogens “superbugs”: a rising public health threat. Front Microbiol. 2023;14.

Damjanova I, Tóth A, Pászti J, et al. Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type beta-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005--the new 'MRSAs'?. J Antimicrob Chemother. 2008;62(5):978–85. https://doi.org/10.1093/jac/dkn287.

Coelho A, Mirelis B, Alonso-Tarrés C, Larrosa MN, Miró E, Abad RC, et al. Detection of three stable genetic clones of CTX-M-15-producing Klebsiella pneumoniae in the Barcelona metropolitan area, Spain. J Antimicrob Chemother. 2009;64:862–4.

Article  CAS  PubMed  Google Scholar 

Rodrigues C, Desai S, Passet V, Gajjar D, Brisse S. Genomic evolution of the globally disseminated multidrug-resistant Klebsiella pneumoniae clonal group 147. Microb Genom. 2022;8.

Avgoulea K, Pilato V di, Zarkotou O, Sennati S, Politi L, Cannatelli A, et al. Characterization of extensively drug-resistant or Pandrug-resistant sequence type 147 and 101 OXA-48-producing Klebsiella pneumoniae causing bloodstream infections in patients in an intensive care unit. Antimicrob Agents Chemother 2018;62.

Biedrzycka M, Urbanowicz P, Guzek A, Brisse S, Gniadkowski M, Izdebski R. Dissemination of Klebsiella pneumoniae ST147 NDM-1 in Poland, 2015-19. J Antimicrob Chemother. 2021;76:2538–45.

Article  CAS  PubMed  Google Scholar 

Lapp Z, Crawford R, Miles-Jay A, Pirani A, Trick WE, Weinstein RA, et al. Regional spread of blaNDM-1-containing Klebsiella pneumoniae ST147 in post-acute care facilities. Clin Infect Dis. 2021;73:1431–9.

Article  PubMed  PubMed Central  Google Scholar 

Di Pilato V, Henrici De Angelis L, Aiezza N, Baccani I, Niccolai C, Parisio EM, et al. Resistome and virulome accretion in an NDM-1-producing ST147 sublineage of Klebsiella pneumoniae associated with an outbreak in Tuscany, Italy: a genotypic and phenotypic characterisation. Lancet Microbe. 2022;3:e224–34.

Article  PubMed  Google Scholar 

Rojas LJ, Hujer AM, Rudin SD, Wright MS, Domitrovic TN, Marshall SH, et al. NDM-5 and OXA-181 beta-lactamases, a significant threat continues to spread in the Americas. Antimicrob Agents Chemother. 2017;61.

Peirano G, Pillai DR, Pitondo-Silva A, Richardson D, Pitout JDD. The characteristics of NDM-producing Klebsiella pneumoniae from Canada. Diagn Microbiol Infect Dis. 2011;71:106–9.

Article  CAS  PubMed  Google Scholar 

Hornsey M, Phee L, Wareham DW. A novel variant, NDM-5, of the New Delhi Metallo-β-lactamase in a multidrug-resistant Escherichia coli ST648 isolate recovered from a patient in the United Kingdom. Antimicrob Agents Chemother. 2011;55:5952–4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bean DC, Agarwal A, Cherian BP, Wareham DW. Hypermucoviscous polymyxin-resistant Klebsiella pneumoniae from Kolkata, India: genomic and phenotypic analysis. J Glob Antimicrob Resist. 2019;17:1–2.

Article  PubMed  Google Scholar 

Dey S, Gaur M, Sahoo RK, Das A, Jain B, Pati S, et al. Genomic characterization of XDR Klebsiella pneumoniae ST147 co-resistant to carbapenem and colistin – the first report in India. J Glob Antimicrob Resist. 2020;22:54–6.

Article  PubMed  Google Scholar 

Pragasam AK, Shankar C, Veeraraghavan B, Biswas I, Nabarro LEB, Inbanathan FY, et al. Molecular mechanisms of Colistin resistance in Klebsiella pneumoniae causing bacteremia from India—a first report. Front Microbiol. 2016;7:2135.

PubMed  Google Scholar 

Wood SJ, Kuzel TM, Shafikhani SH. Pseudomonas aeruginosa: infections, animal modeling, and therapeutics. Cells. 2023;12.

Beg AZ, Rashid F, Talat A, Haseen MA, Raza N, Akhtar K, et al. Functional amyloids in Pseudomonas aeruginosa are essential for the proteome modulation that leads to Pathoadaptation in pulmonary niches. Microbiol Spectr. 2023;11.

Langendonk RF, Neill DR, Fothergill JL. The building blocks of antimicrobial resistance in Pseudomonas aeruginosa: implications for current resistance-breaking therapies. Front Cell Infect Microbiol. 2021;11.

Treepong P, Kos VN, Guyeux C, Blanc DS, Bertrand X, Valot B, et al. Global emergence of the widespread Pseudomonas aeruginosa ST235 clone. Clin Microbiol Infect. 2018;24:258–66.

Article  CAS  PubMed  Google Scholar 

del Barrio-Tofiño E, López-Causapé C, Oliver A. Pseudomonas aeruginosa epidemic high-risk clones and their association with horizontally-acquired β-lactamases: 2020 update. Int J Antimicrob Agents. 2020;56.

Karampatakis T, Tsergouli K, Behzadi P. Pan-genome plasticity and virulence factors: a natural treasure trove for Acinetobacter baumannii. Antibiotics (Basel). 2024;13:257.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Behzadi P, Gajdács M, Pallós P, Ónodi B, Stájer A, Matusovits D, et al. Relationship between biofilm-formation, phenotypic virulence factors and antibiotic resistance in environmental Pseudomonas aeruginosa. Pathogens. 2022;11.

Tuon FF, Dantas LR, Suss PH, Tasca Ribeiro VS. Pathogenesis of the Pseudomonas aeruginosa biofilm: a review. Pathogens. 2022;11.

Li Y, Ni M. Regulation of biofilm formation in Klebsiella pneumoniae. Front Microbiol. 2023;14.

Qin S, Xiao W, Zhou C, Pu Q, Deng X, Lan L, et al. Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics. Signal Transduct Target Ther. 2022;7:1–27.

PubMed  PubMed Central  Google Scholar 

Santajit S, Sookrung N, Indrawattana N. Quorum sensing in ESKAPE bugs: a target for combating antimicrobial resistance and bacterial virulence. Biology. 2022;11:1466.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Laxminarayan R, Chaudhury RR. Antibiotic resistance in India: drivers and opportunities for action. PLoS Med. 2016;13.

Khurana S, Malhotra R, Mathur P. Evaluation of Vitek®2 performance for colistin susceptibility testing for gram-negative isolates. JAC Antimicrob Resist. 2020;2.

Tripathi N, Sapra A. Gram Staining. StatPearls; 2023.

Google Scholar 

Pages Monteiro L, Von Allmen N, Friesen I, Huth K, Zambardi G. Performance of the VITEK®2 advanced expert system™ for the validation of antimicrobial susceptibility testing results. Eur J Clin Microbiol Infect Dis. 2021;40:1333–5.

Article  CAS  PubMed  Google Scholar 

Kowalska-Krochmal B, Dudek-Wicher R. The minimum inhibitory concentration of antibiotics: methods, interpretation, clinical relevance. Pathogens. 2021;10:1–21.

Article  Google Scholar 

留言 (0)

沒有登入
gif